The future of evidence synthesis in Cochrane

In February 2022 the Cochrane Governing Board approved a new model for producing Cochrane Evidence Syntheses, following an extensive community consultation process. The new model is designed to ensure Cochrane remains viable, sustainable, and focused on the greatest global health and care challenges now and into the future. 

We understand that people have specific questions and we’ll answer as many of these as we can, as soon as we can. We also know that organizational transformation on this scale can only happen in stages and that means that we can’t provide answers to all questions immediately. We know there is much uncertainty about how the changes will affect individuals, Cochrane groups, and our collective culture. To help alleviate the concerns that arise during a long transition period we are committed to sharing information as the programme evolves. We will continue to post all details of change-related news and events here - this is your landing page for all information on the future of evidence synthesis in Cochrane. 

Find out more:

This is just the beginning of a profound change for our organization and there is much work to be done. While some answers make take longer to find than others to, we ask you to contribute your questions, concerns, and ideas along the way. The decisions we collectively make now can build on our legacy and foster new opportunities for people to work together to address the most pressing of global issues.